Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00702
|
|||||
| Drug Name |
Telaprevir
|
|||||
| Synonyms |
(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-6-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide; 402957-28-2; 655M5O3W0U; CHEBI:68595; CHEMBL231813; Incivek; Incivo; LY-570310; MP-424; S-Telaprevir; Telaprevir (VX-950); Telavic; UNII-655M5O3W0U; VRT-111950; VX 950; VX-950; VX-950(Telaprevir)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Hepatitis C virus infection [ICD11: 1E50.2, 1E51.1] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C36H53N7O6
|
|||||
| Canonical SMILES |
CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5
|
|||||
| InChI |
InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1
|
|||||
| InChIKey |
BBAWEDCPNXPBQM-GDEBMMAJSA-N
|
|||||
| CAS Number |
CAS 304853-42-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 679.8 | Topological Polar Surface Area | 180 | ||
| Heavy Atom Count | 49 | Rotatable Bond Count | 14 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
4.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10039409
, 103533130
, 109693015
, 111630651
, 123105171
, 126578521
, 126666050
, 126727848
, 134223970
, 134340525
, 134340605
, 135692887
, 136920427
, 137188810
, 137273793
, 141479428
, 143498830
, 14839657
, 152234951
, 152258142
, 152344432
, 160645797
, 160646981
, 162011420
, 162197409
, 16347884
, 163884617
, 164193943
, 164765234
, 175266405
, 175426470
, 175427024
, 176250091
, 184812119
, 198992420
, 223366200
, 223385689
, 223669631
, 224452297
, 226544280
, 248618622
, 249810645
, 249821696
, 251916476
, 36059235
, 3723201
, 49684228
, 80491883
, 96025695
, 99455178
|
|||||
| ChEBI ID |
CHEBI:68595
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Telaprevir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Drug interactions and protease inhibitors used in the treatment of hepatitis C: how to manage? Eur J Clin Pharmacol. 2014 Jul;70(7):775-89. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.